CoChat
Sign Up
Cited by 87

Brain modulation by the gut microbiota: From disease to therapy

Mitra, Sarmistha, Dash, Raju, Nishan, Amena Al, Habiba, Sarmin Ummey, Moon, Il Soo·2023·Journal of Advanced Research
DOI 10.1016/j.jare.2022.12.001PMC PMC10658262
Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jare.2022.12.001

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 256

  1. [1]Gomaa E.Z. Human gut microbiota/microbiome in health and diseases: a review Antonie Van Leeuwenhoek 113 2020 2019 2040 10.1007/s10482-020-01474-7 33136284 · DOI · Paper page
  2. [3]Carabotti M. Scirocco A. Maselli M.A. Severi C. The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems Ann Gastroenterol 28 2015 203 209 25830558 PMC4367209
  3. [6]Varesi A. Pierella E. Romeo M. Piccini G.B. Alfano C. Bjørklund G. The potential role of gut microbiota in Alzheimer’s disease: From diagnosis to treatment Nutrients 14 2022 668 10.3390/nu14030668 35277027 PMC8840394 · DOI · Paper page
  4. [7]Blacher E. Bashiardes S. Shapiro H. Rothschild D. Mor U. Dori-Bachash M. Potential roles of gut microbiome and metabolites in modulating ALS in mice Nature 572 2019 474 480 10.1038/s41586-019-1443-5 31330533 · DOI · Paper page
  5. [8]O'Keefe S.J.D. Diet, microorganisms and their metabolites, and colon cancer Nat Rev Gastroenterol Hepatol 13 2016 691 706 10.1038/nrgastro.2016.165 27848961 PMC6312102 · DOI · Paper page
  6. [9]Mittal R. Debs L.H. Patel A.P. Nguyen D. Patel K. O'Connor G. Neurotransmitters: The critical modulators regulating gut–brain axis J Cell Physiol 232 2017 2359 2372 10.1002/jcp.25518 27512962 PMC5772764 · DOI
  7. [10]Bravo J.A. Forsythe P. Chew M.V. Escaravage E. Savignac H.M. Dinan T.G. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve Proc Natl Acad Sci USA 108 2011 16050 16055 10.1073/pnas.1102999108 21876150 PMC3179073 · DOI · Paper page
  8. [11]Hasan N. Yang H. Factors affecting the composition of the gut microbiota, and its modulation PeerJ 7 2019 e7502 10.7717/peerj.7502 PMC6699480 31440436 · DOI
  9. [12]Myers S.P. Hawrelak J.A. The causes of intestinal dysbiosis: a review, Altern Med Rev 9 2004 180 197 15253677
  10. [14]Gubert C. Kong G. Renoir T. Hannan A.J. Exercise, diet and stress as modulators of gut microbiota: Implications for neurodegenerative diseases Neurobiol Dis 134 2020 104621 10.1016/j.nbd.2019.104621 31628992 · DOI
  11. [15]Chitnis T. Weiner H.L. CNS inflammation and neurodegeneration J Clin Invest 127 2017 3577 3587 28872464 PMC5617655
  12. [17]Kesika P. Suganthy N. Sivamaruthi B.S. Chaiyasut C. Role of gut-brain axis, gut microbial composition, and probiotic intervention in Alzheimer's disease Life Sci 264 2021 118627 10.1016/j.lfs.2020.118627 33169684 · DOI · Paper page
  13. [18]Guo Q. Jiang X. Ni C. Li L. Chen L. Wang Y. Gut microbiota-related effects of Tanhuo decoction in acute ischemic stroke Oxid Med Cell Longev 2021 2021 5596924 10.1155/2021/5596924 34136066 PMC8175183 · DOI
  14. [19]Suganya K. Koo B.-S. Gut-Brain Axis: Role of gut microbiota on neurological disorders and how probiotics/prebiotics beneficially modulate microbial and immune pathways to improve brain functions Int J Mol Sci 21 2020 7551 10.3390/ijms21207551 33066156 PMC7589356 · DOI
  15. [20]Foster J.A. Rinaman L. Cryan J.F. Stress & the gut-brain axis: Regulation by the microbiome, Neurobiol Stress 7 2017 124 136 10.1016/j.ynstr.2017.03.001 PMC5736941 29276734 · DOI · Paper page
  16. [21]Quigley E.M.M. Microbiota-brain-gut axis and neurodegenerative diseases Curr Neurol Neurosci Rep 17 2017 94 10.1007/s11910-017-0802-6 29039142 · DOI · Paper page
  17. [22]Dinan T.G. Cryan J.F. Gut instincts: microbiota as a key regulator of brain development, ageing and neurodegeneration J Physiol 595 2017 489 503 10.1113/JP273106 27641441 PMC5233671 · DOI · Paper page
  18. [23]Pellegrini C. Antonioli L. Colucci R. Blandizzi C. Fornai M. Interplay among gut microbiota, intestinal mucosal barrier and enteric neuro-immune system: a common path to neurodegenerative diseases? Acta Neuropathol 136 2018 345 361 10.1007/s00401-018-1856-5 29797112 · DOI · Paper page
  19. [26]Yoo B.B. Mazmanian S.K. The enteric network: Interactions between the immune and nervous systems of the gut Immunity 46 2017 910 926 10.1016/j.immuni.2017.05.011 28636959 PMC5551410 · DOI
  20. [27]Tremlett H. Bauer K.C. Appel-Cresswell S. Finlay B.B. Waubant E. The gut microbiome in human neurological disease: A review Ann Neurol 81 2017 369 382 10.1002/ana.24901 28220542 · DOI · Paper page
  21. [28]Singh V. Roth S. Llovera G. Sadler R. Garzetti D. Stecher B. Microbiota dysbiosis controls the neuroinflammatory response after stroke J Neurosci 36 2016 7428 10.1523/JNEUROSCI.1114-16.2016 27413153 PMC6705544 · DOI
  22. [29]Ma Q. Xing C. Long W. Wang H.Y. Liu Q. Wang R.-F. Impact of microbiota on central nervous system and neurological diseases: the gut-brain axis J Neuroinflammation 16 2019 53 10.1186/s12974-019-1434-3 30823925 PMC6397457 · DOI
  23. [30]Farzi A. Fröhlich E.E. Holzer P. Gut microbiota and the neuroendocrine system Neurotherapeutics 15 2018 5 22 10.1007/s13311-017-0600-5 29380303 PMC5794709 · DOI · Paper page
  24. [31]El Aidy S. Dinan T.G. Cryan J.F. Gut Microbiota: The conductor in the orchestra of immune-neuroendocrine communication Clin Ther 37 2015 954 967 10.1016/j.clinthera.2015.03.002 25846319 · DOI · Paper page
  25. [32]Wang H.X. Wang Y.P. Gut microbiota-brain axis Chin Med J (Engl) 129 2016 2373 2380 10.4103/0366-6999.190667 27647198 PMC5040025 · DOI · Paper page
  26. [33]de Punder K. Pruimboom L. Stress induces endotoxemia and low-grade inflammation by increasing barrier permeability Front Immunol 6 2015 223 10.3389/fimmu.2015.00223 26029209 PMC4432792 · DOI · Paper page
  27. [34]Round J.L. Mazmanian S.K. The gut microbiota shapes intestinal immune responses during health and disease Nat Rev Immunol 9 2009 313 323 10.1038/nri2515 19343057 PMC4095778 · DOI · Paper page
  28. [35]Chey W.Y. Jin H.O. Lee M.H. Sun S.W. Lee K.Y. Colonic motility abnormality in patients with irritable bowel syndrome exhibiting abdominal pain and diarrhea Am J Gastroenterol 96 2001 1499 1506 10.1111/j.1572-0241.2001.03804.x 11374689 · DOI · Paper page
  29. [36]Bailey M.T. Dowd S.E. Galley J.D. Hufnagle A.R. Allen R.G. Lyte M. Exposure to a social stressor alters the structure of the intestinal microbiota: implications for stressor-induced immunomodulation Brain Behav Immun 25 2011 397 407 10.1016/j.bbi.2010.10.023 21040780 PMC3039072 · DOI · Paper page
  30. [37]Cummings J.H. Short chain fatty acids in the human colon Gut 22 1981 763 779 7028579 PMC1419865
  31. [38]Dalile B. Van Oudenhove L. Vervliet B. Verbeke K. The role of short-chain fatty acids in microbiota–gut–brain communication Nat Rev Gastroenterol Hepatol 16 2019 461 478 10.1038/s41575-019-0157-3 31123355 · DOI · Paper page
  32. [39]Reigstad C.S. Salmonson C.E. Iii J.F.R. Szurszewski J.H. Linden D.R. Sonnenburg J.L. Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells FASEB J 29 2015 1395 1403 10.1096/fj.14-259598 25550456 PMC4396604 · DOI · Paper page
  33. [40]Yano J.M. Yu K. Donaldson G.P. Shastri G.G. Ann P. Ma L. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis Cell 161 2015 264 276 10.1016/j.cell.2015.02.047 25860609 PMC4393509 · DOI · Paper page
  34. [42]Usami M. Kishimoto K. Ohata A. Miyoshi M. Aoyama M. Fueda Y. Butyrate and trichostatin A attenuate nuclear factor kappaB activation and tumor necrosis factor alpha secretion and increase prostaglandin E2 secretion in human peripheral blood mononuclear cells Nutr Res 28 2008 321 328 10.1016/j.nutres.2008.02.012 19083427 · DOI
  35. [43]Furusawa Y. Obata Y. Fukuda S. Endo T.A. Nakato G. Takahashi D. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells Nature 504 2013 446 450 24226770
  36. [44]Rooks M.G. Garrett W.S. Gut microbiota, metabolites and host immunity Nat Rev Immunol 16 2016 341 352 10.1038/nature12721 27231050 PMC5541232 · DOI · Paper page
  37. [45]Priyadarshini M. Kotlo K.U. Dudeja P.K. Layden B.T. Role of short chain fatty acid receptors in intestinal physiology and pathophysiology Compr Physiol 8 2018 1091 1115 10.1002/cphy.c170050 29978895 PMC6058973 · DOI
  38. [46]Pluznick J. A novel SCFA receptor, the microbiota, and blood pressure regulation Gut Microbes 5 2014 202 207 10.4161/gmic.27492 24429443 PMC4063845 · DOI · Paper page
  39. [47]Yang G. Chen S. Deng B. Tan C. Deng J. Zhu G. Implication of G protein-coupled receptor 43 in intestinal inflammation: A mini-review Front Immunol 9 2018 10.3389/fimmu.2018.01434 PMC6023978 29988393 · DOI
  40. [48]Erny D. Hrabě de Angelis A.L. Jaitin D. Wieghofer P. Staszewski O. David E. Host microbiota constantly control maturation and function of microglia in the CNS Nat Neurosci 18 2015 965 977 10.1038/nn.4030 26030851 PMC5528863 · DOI · Paper page
  41. [49]Clarke T.B. Davis K.M. Lysenko E.S. Zhou A.Y. Yu Y. Weiser J.N. Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity Nat Med 16 2010 228 231 10.1038/nm.2087 20081863 PMC4497535 · DOI · Paper page
  42. [50]Rhee S.H. Kim H. Moyer M.P. Pothoulakis C. Role of MyD88 in phosphatidylinositol 3-kinase activation by flagellin/toll-like receptor 5 engagement in colonic epithelial cells J Biol Chem 281 2006 18560 18568 10.1074/jbc.M513861200 16644730 · DOI · Paper page
  43. [51]Charrier L. Driss A. Yan Y. Nduati V. Klapproth J.-M. Sitaraman S.V. hPepT1 mediates bacterial tripeptide fMLP uptake in human monocytes Lab Invest 86 2006 490 503 10.1038/labinvest.3700413 16568107 · DOI · Paper page
  44. [52]Mazzoli R. Pessione E. The neuro-endocrinological role of microbial glutamate and GABA signaling Front Microbiol 7 2016 10.3389/fmicb.2016.01934 PMC5127831 27965654 · DOI · Paper page
  45. [53]Sivamaruthi B.S. Madhumita R. Balamurugan K. Emmanuvel Rajan K. Cronobacter sakazakii infection alters serotonin transporter and improved fear memory retention in the rats Front Pharmacol 6 2015 10.3389/fphar.2015.00188 PMC4560023 26388777 · DOI
  46. [55]Wikoff W.R. Anfora A.T. Liu J. Schultz P.G. Lesley S.A. Peters E.C. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites Proc Natl Acad Sci U S A 106 2009 3698 3703 10.1073/pnas.0812874106 19234110 PMC2656143 · DOI · Paper page
  47. [59]van de Wouw M. Schellekens H. Dinan T.G. Cryan J.F. Microbiota-gut-brain axis: Modulator of host metabolism and appetite Nutr J 147 2017 727 745 10.3945/jn.116.240481 28356427 · DOI · Paper page
  48. [61]Lyte M. Probiotics function mechanistically as delivery vehicles for neuroactive compounds: Microbial endocrinology in the design and use of probiotics Bioessays 33 2011 574 581 10.1002/bies.201100024 21732396 · DOI · Paper page
  49. [62]Sarkar A. Lehto S.M. Harty S. Dinan T.G. Cryan J.F. Burnet P.W.J. Psychobiotics and the manipulation of bacteria-gut-brain signals Trends Neurosci 39 2016 763 781 10.1016/j.tins.2016.09.002 27793434 PMC5102282 · DOI · Paper page
  50. [63]Raybould H.E. Gut chemosensing: Interactions between gut endocrine cells and visceral afferents Auton Neurosci 153 2010 41 46 10.1016/j.autneu.2009.07.007 19674941 PMC3014315 · DOI · Paper page
  51. [64]Strader A.D. Woods S.C. Gastrointestinal hormones and food intake Gastroenterology 128 2005 175 191 10.1053/j.gastro.2004.10.043 15633135 · DOI
  52. [65]Li Y. Hao Y. Zhu J. Owyang C. Serotonin released from intestinal enterochromaffin cells mediates luminal non-cholecystokinin-stimulated pancreatic secretion in rats Gastroenterology 118 2000 1197 1207 10.1016/s0016-5085(00)70373-8 10833495 · DOI
  53. [67]Sarubbo F. Cavallucci V. Pani G. The influence of gut microbiota on neurogenesis: Evidence and hopes Cells 11 2022 10.3390/cells11030382 PMC8834402 35159192 · DOI
  54. [68]Ribeiro M.F. Santos A.A. Afonso M.B. Rodrigues P.M. Sá Santos S. Castro R.E. Diet-dependent gut microbiota impacts on adult neurogenesis through mitochondrial stress modulation Brain Commun 2 2020 fcaa165 10.1093/braincomms/fcaa165 33426525 PMC7780462 · DOI
  55. [69]Bhattacharjee S. Lukiw W. Alzheimer's disease and the microbiome Front Cell Neurosci 7 2013 PMC3775450 24062644
  56. [70]Hamilton A. Holscher C. The effect of ageing on neurogenesis and oxidative stress in the APPswe/PS1deltaE9 mouse model of Alzheimer's disease Brain Res 1449 2012 83 93 10.3233/JAD-161141 22418058 · DOI · Paper page
  57. [72]Luck B. Engevik M.A. Ganesh B.P. Lackey E.P. Lin T. Balderas M. Bifidobacteria shape host neural circuits during postnatal development by promoting synapse formation and microglial function Sci Rep 10 2020 7737 10.1038/s41598-020-64173-3 32385412 PMC7210968 · DOI
  58. [73]Fang D. Yan S. Yu Q. Chen D. Yan S.S. Mfn2 is required for mitochondrial development and synapse formation in human induced pluripotent stem cells/hiPSC derived cortical neurons Sci Rep 6 2016 31462 10.1038/srep31462 27535796 PMC4989148 · DOI
  59. [74]Khacho M. Clark A. Svoboda D.S. Azzi J. MacLaurin J.G. Meghaizel C. Mitochondrial dynamics impacts stem cell identity and fate decisions by regulating a nuclear transcriptional program Cell Stem Cell 19 2016 232 247 10.1016/j.stem.2016.04.015 27237737 · DOI
  60. [75]Zhao C. Deng W. Gage F.H. Mechanisms and functional implications of adult neurogenesis Cell 132 2008 645 660 10.1016/j.cell.2008.01.033 18295581 · DOI · Paper page
  61. [76]Clark A. Mach N. The crosstalk between the gut microbiota and mitochondria during exercise Front Physiol 8 2017 10.3389/fphys.2017.00319 PMC5437217 28579962 · DOI
  62. [77]Tang Y. Chen Y. Jiang H. Nie D. Short-chain fatty acids induced autophagy serves as an adaptive strategy for retarding mitochondria-mediated apoptotic cell death Cell Death Differ 18 2011 602 618 10.1038/cdd.2010.117 20930850 PMC3020988 · DOI
  63. [78]Sena L.A. Chandel N.S. Physiological roles of mitochondrial reactive oxygen species Mol Cell 48 2012 158 167 10.1016/j.molcel.2012.09.025 23102266 PMC3484374 · DOI · Paper page
  64. [79]Park H. Poo M.M. Neurotrophin regulation of neural circuit development and function Nat Rev Neurosci 14 2013 7 23 10.1038/nrn3379 23254191 · DOI · Paper page
  65. [80]Sudo N. Chida Y. Aiba Y. Sonoda J. Oyama N. Yu X.N. Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice J Physiol 558 2004 263 275 10.1113/jphysiol.2004.063388 15133062 PMC1664925 · DOI · Paper page
  66. [82]Zeng L. Zeng B. Wang H. Li B. Huo R. Zheng P. Microbiota modulates behavior and protein kinase C mediated cAMP response element-binding protein signaling Sci Rep 6 2016 29998 10.1038/srep29998 27444685 PMC4956747 · DOI
  67. [84]González-Arancibia C. Urrutia-Piñones J. Illanes-González J. Martinez-Pinto J. Sotomayor-Zárate R. Julio-Pieper M. Do your gut microbes affect your brain dopamine? Psychopharmacology 236 2019 1611 1622 10.1007/s00213-019-05265-5 31098656 · DOI
  68. [85]Hamamah S. Aghazarian A. Nazaryan A. Hajnal A. Covasa M. Role of microbiota-gut-brain axis in regulating dopaminergic signaling Biomedicines 10 2022 10.3390/biomedicines10020436 PMC8962300 35203645 · DOI
  69. [86]St R. Laurent L.M. O’Brien S.T.A. Sodium butyrate improves locomotor impairment and early mortality in a rotenone-induced Drosophila model of Parkinson’s disease Neuroscience 246 2013 382 390 10.1016/j.neuroscience.2013.04.037 23623990 PMC3721507 · DOI · Paper page
  70. [87]Freestone P.P. Williams P.H. Haigh R.D. Maggs A.F. Neal C.P. Lyte M. Growth stimulation of intestinal commensal Escherichia coli by catecholamines: a possible contributory factor in trauma-induced sepsis Shock 18 2002 465 470 10.1097/00024382-200211000-00014 12412628 · DOI
  71. [88]Matsumoto M. Kibe R. Ooga T. Aiba Y. Sawaki E. Koga Y. Cerebral low-molecular metabolites influenced by intestinal microbiota: a pilot study Front Syst Neurosci 7 2013 9 10.3389/fnsys.2013.00009 23630473 PMC3632785 · DOI · Paper page
  72. [90]Boonstra E. de Kleijn R. Colzato L.S. Alkemade A. Forstmann B.U. Nieuwenhuis S. Neurotransmitters as food supplements: the effects of GABA on brain and behavior Front Physiol 6 2015 10.3389/fpsyg.2015.01520 PMC4594160 26500584 · DOI
  73. [91]Shandilya S. Kumar S. Kumar Jha N. Kumar Kesari K. Ruokolainen J. Interplay of gut microbiota and oxidative stress: Perspective on neurodegeneration and neuroprotection J Adv Res 38 2022 223 244 10.1016/j.jare.2021.09.005 35572407 PMC9091761 · DOI
  74. [92]Di Meo F. Valentino A. Petillo O. Peluso G. Filosa S. Crispi S. Bioactive polyphenols and neuromodulation: Molecular mechanisms in neurodegeneration Int J Mol Sci 21 2020 2564 10.3390/ijms21072564 32272735 PMC7178158 · DOI
  75. [93]Shabbir U. Tyagi A. Elahi F. Aloo S.O. Oh D.-H. The potential role of polyphenols in oxidative stress and inflammation induced by gut microbiota in Alzheimer’s disease Antioxidants 10 2021 1370 10.3390/antiox10091370 34573002 PMC8472599 · DOI
  76. [95]Goyal D. Ali S.A. Singh R.K. Emerging role of gut microbiota in modulation of neuroinflammation and neurodegeneration with emphasis on Alzheimer's disease Prog Neuropsychopharmacol Biol 106 2021 110112 10.1016/j.pnpbp.2020.110112 32949638 · DOI
  77. [96]Di Meo F. Margarucci S. Galderisi U. Crispi S. Peluso G. Curcumin, gut microbiota, and neuroprotection Nutrients 11 2019 2426 10.3390/nu11102426 31614630 PMC6835970 · DOI
  78. [97]Knapp L.T. Klann E. Role of reactive oxygen species in hippocampal long-term potentiation: contributory or inhibitory? J Neurosci Res 70 2002 1 7 10.1002/jnr.10371 12237859 · DOI
  79. [98]Massaad C.A. Klann E. Reactive oxygen species in the regulation of synaptic plasticity and memory Antioxid Redox Signal 14 2010 2013 2054 10.1089/ars.2010.3208 20649473 PMC3078504 · DOI · Paper page
  80. [99]Needham B.D. Kaddurah-Daouk R. Mazmanian S.K. Gut microbial molecules in behavioural and neurodegenerative conditions Nat Rev Neurosci 21 2020 717 731 10.1038/s41583-020-00381-0 33067567 · DOI · Paper page
  81. [100]Vaz A.R. Cunha C. Gomes C. Schmucki N. Barbosa M. Brites D. Glycoursodeoxycholic acid reduces matrix metalloproteinase-9 and caspase-9 activation in a cellular model of superoxide dismutase-1 neurodegeneration Mol Neurobiol 51 2015 864 877 10.1007/s12035-014-8731-8 24848512 · DOI
  82. [102]Gandy K.A.O. Zhang J. Nagarkatti P. Nagarkatti M. The role of gut microbiota in shaping the relapse-remitting and chronic-progressive forms of multiple sclerosis in mouse models Sci Rep 9 2019 6923 10.1038/s41598-019-43356-7 31061496 PMC6502871 · DOI
  83. [103]Cole G.M. Teter B. Frautschy S.A. Neuroprotective effects of curcumin Adv Exp Med Biol 595 2007 197 212 10.1002/iub.2209 17569212 PMC2527619 · DOI
  84. [105]W. Zam, Gut microbiota as a prospective therapeutic target for curcumin: A review of mutual influence, J. Nutr. Metab. 2018 (2018) 1367984-1367984. doi:10.1155/2018/1367984. PMC6311836 30647970 · DOI
  85. [106]Tan S. Calani L. Bresciani L. Dall'asta M. Faccini A. Augustin M.A. The degradation of curcuminoids in a human faecal fermentation model Int J Food Sci Nutr 66 2015 790 796 10.3109/09637486.2015.1095865 26471074 · DOI
  86. [107]Wei G. Chen B. Lin Q. Li Y. Luo L. He H. Tetrahydrocurcumin provides neuroprotection in experimental traumatic brain injury and the Nrf2 signaling pathway as a potential mechanism Neuroimmunomodulation 24 2017 348 355 10.1159/000487998 29669346 · DOI
  87. [108]Gao Y. Zhuang Z. Gao S. Li X. Zhang Z. Ye Z. Tetrahydrocurcumin reduces oxidative stress-induced apoptosis via the mitochondrial apoptotic pathway by modulating autophagy in rats after traumatic brain injury Am J Transl Res 9 2017 887 899 28386319 PMC5375984
  88. [109]Rajeswari A. Sabesan M. Inhibition of monoamine oxidase-B by the polyphenolic compound, curcumin and its metabolite tetrahydrocurcumin, in a model of Parkinson's disease induced by MPTP neurodegeneration in mice Inflammopharmacology 16 2008 96 99 10.1007/s10787-007-1614-0 18408903 · DOI
  89. [110]Wu J.C. Tsai M.L. Lai C.S. Wang Y.J. Ho C.T. Pan M.H. Chemopreventative effects of tetrahydrocurcumin on human diseases Food Funct 5 2014 12 17 10.1039/c3fo60370a 24220621 · DOI
  90. [111]Hou Y.F. Shan C. Zhuang S.Y. Zhuang Q.Q. Ghosh A. Zhu K.C. Gut microbiota-derived propionate mediates the neuroprotective effect of osteocalcin in a mouse model of Parkinson’s disease Microbiome 9 2021 34 10.1186/s40168-020-00988-6 33517890 PMC7849090 · DOI · Paper page
  91. [113]Sirin S. Aslim B. Characterization of lactic acid bacteria derived exopolysaccharides for use as a defined neuroprotective agent against amyloid beta1–42-induced apoptosis in SH-SY5Y cells Sci Rep 10 2020 8124 10.1038/s41598-020-65147-1 32415207 PMC7229009 · DOI
  92. [114]Park J. Lee J. Yeom Z. Heo D. Lim Y.H. Neuroprotective effect of Ruminococcus albus on oxidatively stressed SH-SY5Y cells and animals Sci Rep 7 2017 14520 10.1038/s41598-017-15163-5 29109537 PMC5674049 · DOI
  93. [115]Ahmed S. Busetti A. Fotiadou P. Vincy Jose N. Reid S. Georgieva M. In vitro characterization of gut microbiota-derived bacterial strains with neuroprotective properties Front Cell Neurosci 13 2019 10.3389/fncel.2019.00402 PMC6763572 31619962 · DOI
  94. [116]Sharma S. Taliyan R. Singh S. Beneficial effects of sodium butyrate in 6-OHDA induced neurotoxicity and behavioral abnormalities: Modulation of histone deacetylase activity Behav Brain Res 291 2015 306 314 10.1016/j.bbr.2015.05.052 26048426 · DOI · Paper page
  95. [117]Paiva I. Pinho R. Pavlou M.A. Hennion M. Wales P. Schütz A.L. Sodium butyrate rescues dopaminergic cells from alpha-synuclein-induced transcriptional deregulation and DNA damage Hum Mol Genet 26 2017 2231 2246 10.1093/hmg/ddx114 28369321 · DOI · Paper page
  96. [118]Gurbani S.S. Yoon Y. Weinberg B.D. Salgado E. Press R.H. Cordova J.S. Assessing treatment response of glioblastoma to an HDAC inhibitor using whole-brain spectroscopic MRI Tomography 5 2019 53 60 10.18383/j.tom.2018.00031 30854442 PMC6403031 · DOI
  97. [119]Zhou Z. Xu N. Matei N. McBride D.W. Ding Y. Liang H. Sodium butyrate attenuated neuronal apoptosis via GPR41/Gβγ/PI3K/Akt pathway after MCAO in rats J Cereb Blood Flow Metab 41 2020 267 281 10.1177/0271678X20910533 32151222 PMC8370004 · DOI
  98. [120]Zhu S. Jiang Y. Xu K. Cui M. Ye W. Zhao G. The progress of gut microbiome research related to brain disorders J Neuroinflammation 17 2020 25 10.1186/s12974-020-1705-z 31952509 PMC6969442 · DOI · Paper page
  99. [121]Pluta R. Ułamek-Kozioł M. Januszewski S. Czuczwar S.J. Gut microbiota and pro/prebiotics in Alzheimer's disease Aging (Albany NY) 12 2020 5539 5550 10.18632/aging.102930 32191919 PMC7138569 · DOI
  100. [122]R. Pluta, M. Ułamek-Kozioł, S. Januszewski, S.J. Czuczwar 2021 Alzheimer's disease facts and figures, Alzheimers Dement. 17 (2021) 327-406. doi:10.1002/alz.12328. 33756057 · DOI
  101. [123]Scheltens P. De Strooper B. Kivipelto M. Holstege H. Chételat G. Teunissen C.E. Alzheimer's disease Lancet 397 2021 1577 1590 10.1016/S0140-6736(20)32205-4 33667416 PMC8354300 · DOI · Paper page
  102. [124]Sengoku R. Aging and Alzheimer's disease pathology Neuropathology 40 2020 22 29 10.1111/neup.12626 31863504 · DOI
  103. [125]Wood J.G. Mirra S.S. Pollock N.J. Binder L.I. Neurofibrillary tangles of Alzheimer disease share antigenic determinants with the axonal microtubule-associated protein tau (tau) Proc Natl Acad Sci USA 83 1986 4040 4043 10.1073/pnas.83.11.4040 2424015 PMC323661 · DOI
  104. [126]De-Paula V.J. Radanovic M. Diniz B.S. Forlenza O.V. Alzheimer’s Disease Harris J.R. Protein Aggregation and Fibrillogenesis in Cerebral and Systemic Amyloid Disease 2012 Dordrecht Springer, Netherlands 329 352
  105. [127]Breijyeh Z. Karaman R. Comprehensive review on Alzheimer's disease: Causes and treatment Molecules 25 2020 10.3390/molecules25245789 PMC7764106 33302541 · DOI · Paper page
  106. [128]Lei P. Ayton S. Bush A.I. The essential elements of Alzheimer's disease J Biol Chem 296 2021 100105 10.1074/jbc.REV120.008207 PMC7948403 33219130 · DOI
  107. [130]Gun R.T. Korten A.E. Jorm A.F. Henderson A.S. Broe G.A. Creasey H. Occupational risk factors for Alzheimer disease: a case-control study Alzheimer Dis Assoc Disord 11 1997 21 27 10.1097/00002093-199703000-00005 9071441 · DOI
  108. [131]Hoogmartens J. Cacace R. Van Broeckhoven C. Insight into the genetic etiology of Alzheimer's disease: A comprehensive review of the role of rare variants Alzheimers Dement (Amst) 13 2021 e12155 10.1002/dad2.12155 PMC7896636 33665345 · DOI
  109. [132]Oxford A.E. Stewart E.S. Rohn T.T. Clinical trials in Alzheimer’s disease: A hurdle in the path of remedy Int J Alzheimers Dis 2020 2020 10.1155/2020/5380346 PMC7152954 32308993 · DOI
  110. [133]Anderson R.M. Hadjichrysanthou C. Evans S. Wong M.M. Why do so many clinical trials of therapies for Alzheimer's disease fail? Lancet 390 2017 2327 2329 10.1016/S0140-6736(17)32399-1 29185425 · DOI · Paper page
  111. [134]Schott J.M. Aisen P.S. Cummings J.L. Howard R.J. Fox N.C. Unsuccessful trials of therapies for Alzheimer's disease Lancet 393 2019 29 10.1016/S0140-6736(18)31896-8 30614456 · DOI
  112. [136]Jiang C. Li G. Huang P. Liu Z. Zhao B. The gut microbiota and Alzheimer's disease J Alzheimers Dis 58 2017 1 15 10.3233/JAD-161141 28372330 · DOI · Paper page
  113. [137]Cattaneo A. Cattane N. Galluzzi S. Provasi S. Lopizzo N. Festari C. Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly Neurobiol Aging 49 2017 60 68 10.1016/j.neurobiolaging.2016.08.019 27776263 · DOI · Paper page
  114. [138]Liu P. Wu L. Peng G. Han Y. Tang R. Ge J. Altered microbiomes distinguish Alzheimer's disease from amnestic mild cognitive impairment and health in a Chinese cohort Brain Behav Immun 80 2019 633 643 10.1016/j.bbi.2019.05.008 31063846 · DOI · Paper page
  115. [139]Haran J.P. Bhattarai S.K. Foley S.E. Dutta P. Ward D.V. Bucci V. Alzheimer's disease microbiome is associated with dysregulation of the anti-inflammatory P-glycoprotein pathway mBio 10 2019 10.1128/mBio.00632-19 PMC6509190 31064831 · DOI · Paper page
  116. [140]Giovannini M.G. Lana D. Traini C. Vannucchi M.G. The microbiota–gut–brain axis and Alzheimer disease. From dysbiosis to neurodegeneration: Focus on the central nervous system glial cells J Clin Med 10 2021 10.3390/jcm10112358 PMC8199461 34072107 · DOI
  117. [141]Kincaid H.J. Nagpal R. Yadav H. Diet-microbiota-brain axis in Alzheimer’s disease Ann Nutr Metab 77 2021 21 27 10.1159/000515700 33906194 PMC10202336 · DOI
  118. [142]Bonfili L. Cecarini V. Gogoi O. Gong C. Cuccioloni M. Angeletti M. Microbiota modulation as preventative and therapeutic approach in Alzheimer’s disease FEBS Lett 288 2021 2836 2855 10.1111/febs.15571 32969566 · DOI
  119. [143]Parada Venegas D. De la Fuente M.K. Landskron G. González M.J. Quera R. Dijkstra G. Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases Front Immunol 2019 277 10.3389/fimmu.2019.00277 30915065 PMC6421268 · DOI · Paper page
  120. [145]Ho L. Ono K. Tsuji M. Mazzola P. Singh R. Pasinetti G.M. Protective roles of intestinal microbiota derived short chain fatty acids in Alzheimer’s disease-type beta-amyloid neuropathological mechanisms Expert Rev Neurother 18 2018 83 90 10.1080/14737175.2018.1400909 29095058 PMC5958896 · DOI · Paper page
  121. [146]Brown R.H. Al-Chalabi A. Amyotrophic lateral sclerosis N Engl J Med 377 2017 162 172 28700839
  122. [147]van Es M.A. Hardiman O. Chio A. Al-Chalabi A. Pasterkamp R.J. Veldink J.H. Amyotrophic lateral sclerosis Lancet 390 2017 2084 2098 10.1016/S0140-6736(17)31287-4 28552366 · DOI
  123. [148]Hardiman O. Al-Chalabi A. Chio A. Corr E.M. Logroscino G. Robberecht W. Amyotrophic lateral sclerosis Nat Rev Dis 3 2017 1 19 10.1038/nrdp.2017.71 28980624 · DOI
  124. [149]Masrori P. Van Damme P. Amyotrophic lateral sclerosis: a clinical review Eur J Neurol 27 2020 1918 1929 10.1038/nrdp.2017.71 32526057 PMC7540334 · DOI
  125. [150]Phukan J. Pender N.P. Hardiman O. Cognitive impairment in amyotrophic lateral sclerosis Lancet Neurol 6 2007 994 1003 17945153
  126. [151]Chio A. Logroscino G. Hardiman O. Swingler R. Mitchell D. Beghi E. Prognostic factors in ALS: a critical review Amyotroph Lateral Scler 10 2009 310 323 10.3109/17482960802566824 19922118 PMC3515205 · DOI · Paper page
  127. [152]Neumann M. Sampathu D.M. Kwong L.K. Truax A.C. Micsenyi M.C. Chou T.T. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis Science 314 2006 130 133 10.1126/science.1134108 17023659 · DOI · Paper page
  128. [153]Rosen D.R. Siddique T. Patterson D. Figlewicz D.A. Sapp P. Hentati A. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis Nature 362 1993 59 62 10.1038/364362c0 8446170 · DOI · Paper page
  129. [154]Kwiatkowski T. Jr Bosco D. Leclerc A. Tamrazian E. Vanderburg C. Russ C. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis Science 323 2009 1205 1208 10.1126/science.1166066 19251627 · DOI
  130. [158]Boddy S.L. Giovannelli I. Sassani M. Cooper-Knock J. Snyder M.P. Segal E. The gut microbiome: a key player in the complexity of amyotrophic lateral sclerosis (ALS) BMC Med 19 2021 13 10.1186/s12916-020-01885-3 33468103 PMC7816375 · DOI · Paper page
  131. [162]Figueroa-Romero C. Guo K. Murdock B.J. Paez-Colasante X. Bassis C.M. Mikhail K.A. Temporal evolution of the microbiome, immune system and epigenome with disease progression in ALS mice Dis Model Mech 13 2019 10.1242/dmm.041947 PMC6906635 31597644 · DOI · Paper page
  132. [163]Burberry A. Wells M.F. Limone F. Couto A. Smith K.S. Keaney J. C9orf72 suppresses systemic and neural inflammation induced by gut bacteria Nature 582 2020 89 94 10.1038/s41586-020-2288-7 32483373 PMC7416879 · DOI · Paper page
  133. [164]Gotkine M. Kviatcovsky D. Elinav E. Amyotrophic lateral sclerosis and intestinal microbiota—toward establishing cause and effect Gut Microbes 11 2020 1833 1841 10.1080/19490976.2020.1767464 32501768 PMC7524331 · DOI
  134. [165]Dauer W. Przedborski S. Parkinson's disease: mechanisms and models Neuron 39 2003 889 909 10.1016/s0896-6273(03)00568-3 12971891 · DOI · Paper page
  135. [166]Poewe W. Seppi K. Tanner C.M. Halliday G.M. Brundin P. Volkmann J. Parkinson disease Nat Rev Dis Primers 3 2017 1 21 10.1038/nrdp.2017.13 28332488 · DOI · Paper page
  136. [167]H. Braak, E. Braak, Pathoanatomy of Parkinson’s disease, Journal of Neurology, 247 (2000) II3-II10. doi:10.1007/PL00007758. 10991663 · DOI · Paper page
  137. [168]Wolters E.C. Braak H. Parkinson’s disease: premotor clinico-pathological correlations J Neural Transm Suppl 2006 309 319 10.1007/978-3-211-45295-0_47 17017546 · DOI
  138. [169]Jellinger K.A. Neuropathobiology of non-motor symptoms in Parkinson disease J Neural Transm 122 2015 1429 1440 10.1007/s00702-015-1405-5 25976432 · DOI
  139. [170]Elfil M. Kamel S. Kandil M. Koo B.B. Schaefer S.M. Implications of the gut microbiome in Parkinson's disease Mov Disord 35 2020 921 933 10.1002/mds.28004 32092186 · DOI
  140. [171]Savica R. Carlin J. Grossardt B. Bower J. Ahlskog J. Maraganore D. Medical records documentation of constipation preceding Parkinson disease: a case-control study Neurology 73 2009 1752 1758 10.1212/WNL.0b013e3181c34af5 19933976 PMC2788809 · DOI
  141. [172]Kieburtz K. Wunderle K.B. Parkinson's disease: evidence for environmental risk factors Mov Disord 28 2013 8 13 10.1002/mds.25150 23097348 · DOI
  142. [174]Braak H. de Vos R.A. Bohl J. Del Tredici K. Gastric α-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology Neurosci Lett 396 2006 67 72 10.1016/j.neulet.2005.11.012 16330147 · DOI · Paper page
  143. [175]Su A. Gandhy R. Barlow C. Triadafilopoulos G. A practical review of gastrointestinal manifestations in Parkinson's disease Parkinsonism Relat Disord 39 2017 17 26 10.1016/j.parkreldis.2017.02.029 28258927 · DOI
  144. [177]Eisenhofer G. Åneman A. Friberg P. Hooper D. Fåndriks L. Lonroth H. Substantial production of dopamine in the human gastrointestinal tract J Clin Endocrinol Metab 82 1997 3864 3871 10.1210/jcem.82.11.4339 9360553 · DOI · Paper page
  145. [178]Wall R. Cryan J.F. Ross R.P. Fitzgerald G.F. Dinan T.G. Stanton C. Bacterial neuroactive compounds produced by psychobiotics Adv Exp Med Biol 2014 221 239 10.1007/978-1-4939-0897-4_10 24997036 · DOI
  146. [179]Hamamah S. Aghazarian A. Nazaryan A. Hajnal A. Covasa M. Role of microbiota-gut-brain axis in regulating dopaminergic signaling Biomedicines 10 2022 436 10.3390/biomedicines10020436 35203645 PMC8962300 · DOI
  147. [180]Cryan J.F. Dinan T.G. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour Nat Rev Neurosci 13 2012 701 712 10.1038/nrn3346 22968153 · DOI · Paper page
  148. [181]Petrov V.A. Saltykova I.V. Zhukova I.A. Alifirova V.M. Zhukova N.G. Dorofeeva Y.B. Analysis of gut microbiota in patients with Parkinson’s disease Bull Exp Biol Med 162 2017 734 737 10.1007/s10517-017-3700-7 28429209 · DOI · Paper page
  149. [182]Queipo-Ortuño M.I. Seoane L.M. Murri M. Pardo M. Gomez-Zumaquero J.M. Cardona F. Gut microbiota composition in male rat models under different nutritional status and physical activity and its association with serum leptin and ghrelin levels PLoS One 8 2013 e65465 10.1371/journal.pone.0065465 PMC3665787 23724144 · DOI · Paper page
  150. [184]Breen D.P. Halliday G.M. Lang A.E. Gut–brain axis and the spread of α-synuclein pathology: vagal highway or dead end? Mov Disord 34 2019 307 316 10.1002/mds.27556 30653258 · DOI · Paper page
  151. [185]Chiang H.L. Lin C.H. Altered gut microbiome and intestinal pathology in Parkinson’s disease J Mov Disord 12 2019 67 10.14802/jmd.18067 31158941 PMC6547039 · DOI
  152. [186]T.R. Sampson, J.W. Debelius, T. Thron, S. Janssen, G.G. Shastri, Z.E. Ilhan, et al., Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson’s disease, Cell. 167 (2016) 1469-1480. e1412. doi:10.1016/j.cell.2016.11.018. PMC5718049 27912057 · DOI · Paper page
  153. [187]Schepici G. Silvestro S. Bramanti P. Mazzon E. The gut microbiota in multiple sclerosis: An overview of clinical trials Cell Transplant 28 2019 1507 1527 10.1177/0963689719873890 31512505 PMC6923550 · DOI
  154. [188]Kappos L. Antel J. Comi G. Montalban X. O'connor P. Polman C.H. Oral fingolimod (FTY720) for relapsing multiple sclerosis N Engl J Med 355 2006 1124 1140 10.1056/NEJMoa052643 16971719 · DOI
  155. [189]Frohman E.M. Racke M.K. Raine C.S. Multiple sclerosis—the plaque and its pathogenesis N Engl J Med 354 2006 942 955 10.1056/NEJMra052130 16510748 · DOI
  156. [190]Leray E. Yaouanq J. Le Page E. Coustans M. Laplaud D. Oger J. Evidence for a two-stage disability progression in multiple sclerosis Brain 133 2010 1900 1913 10.1093/brain/awq076 20423930 PMC2892936 · DOI
  157. [191]Coles A.J. Cox A. Le Page E. Jones J. Trip S.A. Deans J. The window of therapeutic opportunity in multiple sclerosis J Neurol 253 2006 98 108 10.1093/brain/awq226 16044212 · DOI
  158. [192]Fifteenth Meeting of the European Neurological Society, 18-22 June 2005, Vienna, Austria. Abstracts, J. Neurol. 252 Suppl 2 (2005) 3-159. doi:10.1007/s00415-005-2001-7. 15940433 · DOI
  159. [193]Chen J. Chia N. Kalari K.R. Yao J.Z. Novotna M. Paz Soldan M.M. Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls Sci Rep 6 2016 28484 10.1038/srep28484 27346372 PMC4921909 · DOI · Paper page
  160. [194]V. Braniste, M. Al-Asmakh, C. Kowal, F. Anuar, A. Abbaspour, M. Tóth, et al., The gut microbiota influences blood-brain barrier permeability in mice, Sci. Transl. Med. 6 (2014) 263ra158-263ra158. doi:10.1126/scitranslmed.3009759. PMC4396848 25411471 · DOI · Paper page
  161. [195]Xu H.M. Huang H.L. Zhou Y.L. Zhao H.L. Xu J. Shou D.W. Fecal microbiota transplantation: A new therapeutic attempt from the gut to the brain Gastroenterol Res Pract 2021 2021 6699268 10.1155/2021/6699268 33510784 PMC7826222 · DOI
  162. [196]Walker F.O. Huntington's disease Lancet 369 2007 218 228 10.1016/S0140-6736(07)60111-1 17240289 · DOI
  163. [197]Andrew S.E. Paul Goldberg Y. Kremer B. Telenius H. Theilmann J. Adam S. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease Nat Genet 4 1993 398 403 10.1038/ng0893-398 8401589 · DOI
  164. [198]Rubinsztein D.C. Barton D.E. Davison B.C. Ferguson-Smith M.A. Analysis of the huntingtin gene reveals a trinucleotide-length polymorphism in the region of the gene that contains two CCG-rich stretches and a correlation between decreased age of onset of Huntington's disease and CAG repeat number Hum Mol Genet 2 1993 1713 1715 10.1093/hmg/2.10.1713 8268927 · DOI
  165. [199]MacDonald M.E. Ambrose C.M. Duyao M.P. Myers R.H. Lin C. Srinidhi L. The Huntington’s Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes Cell 72 1993 971 983 10.1016/0092-8674(93)90585-e 8458085 · DOI · Paper page
  166. [200]Moffitt H. McPhail G.D. Woodman B. Hobbs C. Bates G.P. Formation of polyglutamine inclusions in a wide range of non-CNS tissues in the Hdh Q150 knock-in mouse model of Huntington's disease PLoS One 4 2009 e8025 10.1371/journal.pone.0008025 PMC2778556 19956633 · DOI
  167. [201]Sharp A.H. Loev S.J. Schilling G. Li S.H. Li X.J. Bao J. Widespread expression of Huntington's disease gene (IT15) protein product Neuron 14 1995 1065 1074 10.1016/0896-6273(95)90345-3 7748554 · DOI
  168. [202]Reiner A. Albin R.L. Anderson K.D. D'Amato C.J. Penney J.B. Young A.B. Differential loss of striatal projection neurons in Huntington disease Proc Natl Acad Sci USA 85 1988 5733 5737 10.1073/pnas.85.15.5733 2456581 PMC281835 · DOI
  169. [203]Rosas H.D. Koroshetz W.J. Chen Y.I. Skeuse C. Vangel M. Cudkowicz M.E. Evidence for more widespread cerebral pathology in early HD Neurology 60 2003 1615 10.1212/wnl.62.3.523-a 12771251 · DOI
  170. [204]Arrasate M. Finkbeiner S. Protein aggregates in Huntington's disease Exp Neurol 238 2012 1 11 10.1016/j.expneurol.2011.12.013 22200539 PMC3909772 · DOI
  171. [205]M. Goyal, S. Singh, E.M.S. Sibinga, N.F. Gould, A. Rowland-Seymour, R. Sharma, et al., AHRQ comparative effectiveness reviews, meditation programs for psychological stress and well-being, Agency for Healthcare Research and Quality (US). (2014). 24501780
  172. [207]Madison A. Kiecolt-Glaser J.K. Stress, depression, diet, and the gut microbiota: human-bacteria interactions at the core of psychoneuroimmunology and nutrition Curr Opin Behav Sci 28 2019 105 110 10.1016/j.cobeha.2019.01.011 32395568 PMC7213601 · DOI
  173. [208]Takajo T. Tomita K. Tsuchihashi H. Enomoto S. Tanichi M. Toda H. Depression promotes the onset of irritable bowel syndrome through unique dysbiosis in rats Gut Liver 13 2019 325 332 10.5009/gnl18296 30602220 PMC6529174 · DOI
  174. [209]Aguilera M. Vergara P. Martínez V. Stress and antibiotics alter luminal and wall-adhered microbiota and enhance the local expression of visceral sensory-related systems in mice Neurogastroenterol Motil 25 2013 e515 e529 10.1111/nmo.12154 23711047 · DOI · Paper page
  175. [210]Gu X. Zhou J. Zhou Y. Wang H. Si N. Ren W. Huanglian Jiedu decoction remodels the periphery microenvironment to inhibit Alzheimer's disease progression based on the “brain-gut” axis through multiple integrated omics Alzheimers Res Ther 13 2021 44 10.1186/s13195-021-00779-7 33579351 PMC7881564 · DOI · Paper page
  176. [211]Erny D. Hrabě de Angelis A.L. Prinz M. Communicating systems in the body: how microbiota and microglia cooperate Immunology 150 2017 7 15 10.1111/imm.12645 27392533 PMC5341501 · DOI
  177. [212]Colombo A.V. Sadler R.K. Llovera G. Singh V. Roth S. Heindl S. Microbiota-derived short chain fatty acids modulate microglia and promote Aβ plaque deposition eLife 10 2021 e59826 10.7554/eLife.59826 PMC8043748 33845942 · DOI · Paper page
  178. [213]Chen Y. Fang L. Chen S. Zhou H. Fan Y. Lin L. Gut microbiome alterations precede cerebral amyloidosis and microglial pathology in a mouse model of Alzheimer's disease Biomed Res Int 2020 2020 8456596 10.1155/2020/8456596 32596386 PMC7273394 · DOI
  179. [214]Morris G. Berk M. Carvalho A. Caso J.R. Sanz Y. Walder K. The role of the microbial metabolites including tryptophan catabolites and short chain fatty acids in the pathophysiology of immune-inflammatory and neuroimmune disease Mol Neurobiol 54 2017 4432 4451 10.1007/s12035-016-0004-2 27349436 · DOI
  180. [215]Caffino L. Mottarlini F. Fumagalli F. Born to protect: Leveraging BDNF against cognitive deficit in Alzheimer’s disease CNS Drugs 34 2020 281 297 10.1007/s40263-020-00705-9 32052374 · DOI
  181. [216]Fang X. Wang X. Yang S. Meng F. Wang X. Wei H. Evaluation of the microbial diversity in amyotrophic lateral sclerosis using high-throughput sequencing Front Microbiol 7 2016 10.3389/fmicb.2016.01479 PMC5028383 27703453 · DOI
  182. [218]Ngo S.T. Restuadi R. McCrae A.F. Van Eijk R.P. Garton F. Henderson R.D. Progression and survival of patients with motor neuron disease relative to their fecal microbiota Amyotroph Lateral Scler Front Degener 21 2020 549 562 10.1080/21678421.2020.1772825 32643435 · DOI
  183. [219]Zeng Q. Shen J. Chen K. Zhou J. Liao Q. Lu K. The alteration of gut microbiome and metabolism in amyotrophic lateral sclerosis patients Sci Rep 10 2020 1 12 10.1038/s41598-020-69845-8 32747678 PMC7398913 · DOI · Paper page
  184. [220]Erber A.C. Cetin H. Berry D. Schernhammer E.S. The role of gut microbiota, butyrate and proton pump inhibitors in amyotrophic lateral sclerosis: a systematic review Int J Neurosci 130 2020 727 735 10.1080/00207454.2019.1702549 31870202 · DOI
  185. [222]Nishiwaki H. Ito M. Ishida T. Hamaguchi T. Maeda T. Kashihara K. Meta-analysis of gut dysbiosis in Parkinson's disease Mov Disord 35 2020 1626 1635 10.1002/mds.28119 32557853 · DOI · Paper page
  186. [223]H. Nishiwaki, T. Hamaguchi, M. Ito, T. Ishida, T. Maeda, K. Kashihara, et al., Reduction of short-chain fatty acid-producing gut microbiota leads to transition from rapid-eye-movement sleep behavior disorder to Parkinson’s disease, bioRxiv. (2020) 2020.2008.2007.242453. PMC7771407 33293403
  187. [224]Unger M.M. Spiegel J. Dillmann K.-U. Grundmann D. Philippeit H. Bürmann J. Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls Parkinsonism Relat Disord 32 2016 66 72 10.1016/j.parkreldis.2016.08.019 27591074 · DOI · Paper page
  188. [226]Hoyles L. Snelling T. Umlai U.-K. Nicholson J.K. Carding S.R. Glen R.C. Microbiome–host systems interactions: protective effects of propionate upon the blood–brain barrier Microbiome 6 2018 1 13 10.1186/s40168-018-0439-y 29562936 PMC5863458 · DOI · Paper page
  189. [228]Koutzoumis D.N. Vergara M. Pino J. Buddendorff J. Khoshbouei H. Mandel R.J. Alterations of the gut microbiota with antibiotics protects dopamine neuron loss and improve motor deficits in a pharmacological rodent model of Parkinson's disease Exp Neurol 325 2020 113159 10.1016/j.expneurol.2019.113159 31843492 · DOI
  190. [229]Carlessi A.S. Borba L.A. Zugno A.I. Quevedo J. Réus G.Z. Gut microbiota–brain axis in depression: The role of neuroinflammation Eur J Neurosci 53 2021 222 235 10.1111/ejn.14631 31785168 · DOI · Paper page
  191. [230]Sun M.F. Zhu Y.L. Zhou Z.L. Jia X.B. Xu Y.D. Yang Q. Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson’s disease mice: Gut microbiota, glial reaction and TLR4/TNF-α signaling pathway Brain Behav Immun 70 2018 48 60 10.1016/j.bbi.2018.02.005 29471030 · DOI · Paper page
  192. [231]Du G. Dong W. Yang Q. Yu X. Ma J. Gu W. Altered gut microbiota related to inflammatory responses in patients with Huntington’s disease Front Immunol 11 2021 10.3389/fimmu.2020.603594 PMC7933529 33679692 · DOI
  193. [234]C.I. Radulescu, M. Garcia-Miralles, H. Sidik, C.F. Bardile, N.A.B. Mohammad Yusof, H.U. Lee, et al., Manipulation of microbiota reveals altered myelination and white matter plasticity in a model of Huntington disease, bioRxiv. (2018) 413112. doi:10.1016/j.nbd.2020.104744. 30802499 · DOI
  194. [235]Tamtaji O.R. Kouchaki E. Salami M. Aghadavod E. Akbari E. Tajabadi-Ebrahimi M. The effects of probiotic supplementation on gene expression related to inflammation, insulin, and lipids in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled trial J Am Coll Nutr 36 2017 660 665 10.1080/07315724.2017.1347074 28922099 · DOI
  195. [236]Lee Y.K. Menezes J.S. Umesaki Y. Mazmanian S.K. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis Proc Natl Acad Sci U S A 108 Suppl 1 2011 4615 4622 10.1073/pnas.1000082107 20660719 PMC3063590 · DOI · Paper page
  196. [237]Cekanaviciute E. Yoo B.B. Runia T.F. Debelius J.W. Singh S. Nelson C.A. Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models Proc Natl Acad Sci U S A 114 2017 10713 10718 10.1073/pnas.1711235114 28893978 PMC5635915 · DOI
  197. [238]Yokote H. Miyake S. Croxford J.L. Oki S. Mizusawa H. Yamamura T. NKT cell-dependent amelioration of a mouse model of multiple sclerosis by altering gut flora Am J Pathol 173 2008 1714 1723 10.2353/ajpath.2008.080622 18974295 PMC2626383 · DOI
  198. [239]Molina-Torres G. Rodriguez-Arrastia M. Roman P. Sanchez-Labraca N. Cardona D. Stress and the gut microbiota-brain axis Behav Pharmacol 30 2019 10.1097/FBP.0000000000000478 30844962 · DOI
  199. [240]Naseribafrouei A. Hestad K. Avershina E. Sekelja M. Linløkken A. Wilson R. Correlation between the human fecal microbiota and depression Neurogastroenterol Motil 26 2014 1155 1162 10.1111/nmo.12378 24888394 · DOI · Paper page
  200. [242]Gareau M.G. Jury J. MacQueen G. Sherman P.M. Perdue M.H. Probiotic treatment of rat pups normalises corticosterone release and ameliorates colonic dysfunction induced by maternal separation Gut 56 2007 1522 10.1136/gut.2006.117176 17339238 PMC2095679 · DOI · Paper page

200 of 256 shown

Cited by

Sorted by citations

Authors
Mitra, S., Dash, R., Nishan, A. A., Habiba, S. U., & Moon, I. S.
ORCID
Dash, Raju
Venue
Journal of Advanced Research
Publisher
Elsevier BV
Published
2023-11
Volume
53
Pages
153-173
ISSN
2090-1232
DOI
10.1016/j.jare.2022.12.001
PMC
PMC10658262
Cited by
87
References
56
Language
en
Licence
Funders
  • Ministry of Science and ICT, South Korea
  • National Research Foundation of Korea (NRF-2021R1A2C1008564)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review